Acorda Therapeutics, Inc. Intangible Assets, Net (Excluding Goodwill)
Acorda Therapeutics, Inc. had Intangible Assets, Net (Excluding Goodwill) of $22.34 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2024-05-14
- 2024-03-31: Intangible Assets, Net (Excluding Goodwill) $22.34M.
- 2023-12-31: Intangible Assets, Net (Excluding Goodwill) $22.99M.
- 2023-09-30: Intangible Assets, Net (Excluding Goodwill) $282.01M.
- 2023-06-30: Intangible Assets, Net (Excluding Goodwill) $289.70M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2024-03-31 | $22.34M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $22.99M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $282.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $289.70M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $297.39M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $305.09M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $312.78M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $320.47M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $328.23M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $335.98M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $343.73M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $351.48M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $359.25M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $366.98M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $374.74M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $382.50M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $390.31M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $402.33M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $410.02M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $418.00M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $425.78M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $428.57M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $428.57M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $428.76M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $429.79M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $430.60M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $705.14M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $742.70M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $740.84M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $742.24M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $749.41M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $751.52M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $430.49M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $430.86M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $431.28M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $431.76M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $432.15M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $432.82M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $17.46M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $9.28M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $8.76M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $8.95M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $8.77M 10-Q · filed 2012-11-08 | |
| 2011-09-30 | $7.05M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $20.50M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $20.71M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $21.34M 10-K · filed 2012-02-28 | $21.34M 10-K · filed 2011-03-01 |
| 2010-09-30 | $22.01M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $22.66M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $17.15M 10-K · filed 2011-03-01 |